--- title: "Transtrue's controlling shareholder and its concerted parties reduced their holdings by 0.48%" type: "News" locale: "en" url: "https://longbridge.com/en/news/232936742.md" description: "According to the announcement released by Transtrue, the controlling shareholder and its concerted parties, Mr. Wang Guohong and Suzhou Longyue, will cumulatively reduce their holdings of the company's shares by 1.0158 million shares through centralized bidding from February 24, 2025, to March 21, 2025, accounting for 0.48% of the company's total share capital" datetime: "2025-03-24T09:23:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/232936742.md) - [en](https://longbridge.com/en/news/232936742.md) - [zh-HK](https://longbridge.com/zh-HK/news/232936742.md) generator: "portal-rs" --- # Transtrue's controlling shareholder and its concerted parties reduced their holdings by 0.48% According to the announcement from Transtrue (002771.SZ), the controlling shareholder and its concerted actors, Mr. Wang Guohong and Suzhou Longyue, will cumulatively reduce their holdings of the company's shares by 1,015,800 shares through centralized bidding from February 24, 2025, to March 21, 2025, accounting for 0.48% of the company's total share capital ### Related Stocks - [002771.CN](https://longbridge.com/en/quote/002771.CN.md) ## Related News & Research - [Leave a Nest Capital president makes first appearance at TECH GARAGE Seminar in Malaysia](https://longbridge.com/en/news/297597370.md) - [15:00 ETSKYWORTH Sets New Quality/Performance Benchmark in Premium QD-Mini LED Art TVs with the Introduction of the C2 Canvas Art® TV](https://longbridge.com/en/news/297552429.md) - [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md) - [ZTE signs MoU with BBTEC on AI digital infrastructure projects in Thailand](https://longbridge.com/en/news/297585967.md) - [Klaria Pharma plans listing of new warrants linked to rights issue at SEK 0.6 strike](https://longbridge.com/en/news/297582995.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**